Drugs / ChangTai Keli
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02510118 | Jun 2015 → Jun 2016 | colon carcinoma | Nanjing NingQi Medicine Science and Technology Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ChangTai Keli | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02510118 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “the ChangTai Keli corresponding to the traditional Chinese syndrome of dampness stasis type of spleen deficiency, a herbal extract twice daily for 26 weeks for lower dosage” NCT02510118 ↗ |